Network modulation following sham surgery in Parkinson's disease

Area of Science:

• Neuroscience
• Clinical Trials
• Brain Imaging

Background:

• Placebo and sham effects present significant challenges in developing effective therapies for neurological disorders like Parkinson's disease (PD).
• Understanding the neural mechanisms behind these effects is crucial for improving clinical trial design and therapeutic development.

Purpose of the Study:

• To investigate the neural circuitry underlying placebo responses in Parkinson's disease patients undergoing sham surgery.
• To identify potential biomarkers for predicting susceptibility to sham effects and optimizing clinical trial efficiency.

Main Methods:

• Functional brain imaging (metabolic imaging) and network analysis were employed in PD subjects randomized to sham surgery within a gene therapy trial.
• Metabolic imaging was conducted at baseline, 6 months, and 12 months post-sham surgery.
• Clinical ratings were used to assess patient outcomes and correlate them with network activity.

Main Results:

• A distinct cerebello-limbic circuit was associated with the sham response in blinded PD patients, showing increased network expression that correlated with clinical improvements.
• Upon unblinding, this network's expression decreased towards baseline levels.
• No analogous network alterations were observed with open-label levodopa treatment or during natural disease progression.
• Baseline expression of this network predicted sham outcomes, suggesting its potential as a marker for identifying 'sham-susceptible' individuals.

Conclusions:

• The study identified a specific cerebello-limbic network associated with placebo/sham effects in Parkinson's disease.
• This network's activity is modulated by patient blinding and correlates with clinical outcomes.
• Quantitative assessment of this network could enable pre-randomization identification of sham-susceptible subjects, potentially reducing the need for sham interventions and improving clinical trial efficiency.